Pulmonary Hypertension Trial, Recruiting (NCT06299436)

Pulmonary Hypertension Trial, Recruiting NCT06299436 Sponsor: Johns Hopkins University Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT06299436 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 90 years old
People who have been diagnosed with heart failure where the heart is not pumping as strongly as it should (with a specific measurement of heart pumping function at or below a certain level)
People whose blood-thinning medication (either a type called DOAC or vitamin K antagonist) can safely be paused for 48 hours before the procedure

Who may not be able to join:

People who are unable to pause their vitamin K antagonist blood-thinning medication
People whose blood clotting level (measured by a test called INR) is above 1.5 at the time of the procedure
People who are pregnant
People who have been hospitalised or had a significant worsening of their heart condition within the 2 weeks before joining the study
People who have taken part in another clinical trial involving an experimental drug within the 4 weeks before joining the study
People who are unable to lie flat on their back
People who are experiencing heart or circulation instability symptoms while at rest or during the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven Hsu, MD, Johns Hopkins School of Medicine

Phone: 410-502-0955

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06299436

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: 410-502-0955

More information: https://clinicaltrials.gov/study/NCT06299436

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 90 years old
People who have been diagnosed with heart failure where the heart is not pumping as strongly as it should (with a specific measurement of heart pumping function at or below a certain level)
People whose blood-thinning medication (either a type called DOAC or vitamin K antagonist) can safely be paused for 48 hours before the procedure

Who may not be able to join:

People who are unable to pause their vitamin K antagonist blood-thinning medication
People whose blood clotting level (measured by a test called INR) is above 1.5 at the time of the procedure
People who are pregnant
People who have been hospitalised or had a significant worsening of their heart condition within the 2 weeks before joining the study
People who have taken part in another clinical trial involving an experimental drug within the 4 weeks before joining the study
People who are unable to lie flat on their back
People who are experiencing heart or circulation instability symptoms while at rest or during the procedure

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

10 December 2024

Est. completion

31 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Diagnostic accuracy based on Area Under Curve (AUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov